Indonesia's healthtech runs on a few big platforms. Halodoc and Alodokter lead it. Most backers are corporates, banks, and global funds. Here are 11 backing Jakarta healthtech in 2026.
Indonesia's healthtech market is platform-led, and a handful of names set the pace. Halodoc and Alodokter dominate, pulling most of the users and most of the capital.
The backers behind them are mostly large strategics rather than pure venture funds. Hospitals and pharma groups invest too, often with an eye on distribution and clinical reach.
Global health funds join the bigger rounds, and development finance institutions step in to anchor the largest deals. To win them over you need the right backers and a clean set of files, and Ellty keeps your data in one tracked link.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| Novo Holdings | Global health investor | US$10M-$100M+ | Digital health, medtech, pharma | novoholdings.dk |
| Astra International | Conglomerate CVC | US$20M-$100M+ | Telemedicine, e-pharmacy, hospitals | astra.co.id |
| IFC | Development finance institution | US$10M-$100M+ | Health distribution, hospitals, medtech | ifc.org |
| Bio Farma | State pharma fund | Sub-US$5M | Biotech, diagnostics, digital health | biofarma.co.id |
| Siloam (Lippo) | Hospital strategic | Sub-US$5M | Digital health, hospital tech | siloamhospitals.com |
| UOB Venture | Bank-affiliated VC | US$5M-$30M | Healthtech, growth tech | uobvm.com.sg |
| HL Mando | Korean corporate strategic | ~US$3M | Digital health, telemedicine | hlmando.com |
| Samsung Ventures | Global corporate VC | US$1M-$20M | Health, bioengineering, software | samsungventures.com |
| Sequis | Insurer strategic | Strategic, varies | Digital health, insurtech | sequis.co.id |
| Hera Capital | Pan-SEA VC | US$1M-$10M | Digital health, tech | hera-capital.com |
| Golden Gate Ventures | Pan-SEA VC | US$1M-$10M | E-pharmacy, digital health | goldengate.vc |
Health backers study your usage, clinical data, and approval path. Ellty logs every view so you know who is serious.
Start free 14-day trialHealthtech backers fund real clinical proof, not pitches built on ideas alone. Usage figures and patient data carry far more weight than projections.
Regulation shapes every health deal, so investors look for a clear path to approval and scale. They want to see that you understand the rules before you ask them to write a cheque.
Patient data must stay safe at every stage of the process, and a clean due diligence file makes that easy to prove. Ellty gives each fund one tracked link, so you can see who reads your numbers first.
Indonesia counts 622 healthtech companies, of which about 79 have raised funding, drawing roughly US$362 million in total.
Novo Holdings is a global health investor.
Recent Activity: Co-invested in Halodoc's Series D
LinkedIn: Novo Holdings LinkedIn
Sector Focus: Digital health, medtech, pharma
Stage Focus: Growth, late stage
Check Size: US$10M-$100M+
Location: Denmark / Singapore
Website: novoholdings.dk
Astra is a major Indonesian conglomerate.
Recent Activity: Led Halodoc's Series D round
LinkedIn: Astra International LinkedIn
Sector Focus: Telemedicine, e-pharmacy, hospitals
Stage Focus: Growth, strategic
Check Size: US$20M-$100M+
Location: Jakarta
Website: astra.co.id
IFC is the World Bank's private-sector arm.
Recent Activity: Cornerstoned Medela Potentia's 2025 IPO
Sector Focus: Health distribution, hospitals, medtech
Stage Focus: Growth, pre-IPO
Check Size: US$10M-$100M+
Location: Washington DC, USA
Website: ifc.org
Bio Farma runs a state Bio-Health Fund.
Recent Activity: Runs a US$20M Bio-Health Fund
Sector Focus: Biotech, diagnostics, digital health
Stage Focus: Early, growth
Check Size: Sub-US$5M
Location: Bandung, Indonesia
Website: biofarma.co.id
Siloam is Indonesia's largest hospital group.
Recent Activity: Backed health startups like Prixa
LinkedIn: Siloam Hospitals LinkedIn
Sector Focus: Digital health, hospital tech
Stage Focus: Early, strategic
Check Size: Sub-US$5M
Location: Jakarta
Website: siloamhospitals.com
UOB Venture is a bank-affiliated SEA fund.
Recent Activity: Led Halodoc's Series B
LinkedIn: UOB Venture LinkedIn
Sector Focus: Healthtech, growth tech
Stage Focus: Growth
Check Size: US$5M-$30M
Location: Singapore
Website: uobvm.com.sg
Ellty shows when a fund opens your clinical data. Follow up at the right moment, not days later.
Start free 14-day trialHL Mando is a Korean group backing health apps.
Recent Activity: Co-led Alodokter's 2024 round
Sector Focus: Digital health, telemedicine
Stage Focus: Growth, strategic
Check Size: ~US$3M
Location: South Korea
Website: hlmando.com
Samsung Ventures backs health and bio startups.
Recent Activity: Backed telemedicine app Alodokter
LinkedIn: Samsung Ventures LinkedIn
Sector Focus: Health, bioengineering, software
Stage Focus: Growth
Check Size: US$1M-$20M
Location: Seoul, South Korea
Website: samsungventures.com
Sequis is an Indonesian insurer that backs health.
Recent Activity: Led Alodokter's Series C
Sector Focus: Digital health, insurtech
Stage Focus: Growth, strategic
Check Size: Strategic, varies
Location: Jakarta
Website: sequis.co.id
Hera Capital is a pan-SEA fund backing health.
Recent Activity: Joined Alodokter's Series C
Sector Focus: Digital health, tech
Stage Focus: Growth
Check Size: US$1M-$10M
Location: Singapore
Website: hera-capital.com
Golden Gate backs e-pharmacy and digital health.
Recent Activity: Led e-pharmacy Lifepack's Series A
LinkedIn: Golden Gate Ventures LinkedIn
Sector Focus: E-pharmacy, digital health
Stage Focus: Seed, Series A
Check Size: US$1M-$10M
Location: Singapore
Website: goldengate.vc
Indonesia's health market is platform-heavy, and a few large apps have absorbed most of the funding. That concentration pulls strategic backers to the front of nearly every round.
Astra and the hospital groups put money behind these platforms directly. Pharma companies and insurers join in, drawn by the distribution and data these apps control.
A strategic deal brings real reach as well as capital. It links you to startups and clinics, and Ellty lets you share with each one while you track every open with document analytics.
Tens of millions of Indonesians now use telemedicine, and the state has folded it into the BPJS system. That official backing has turned a convenience into a mainstream channel.
E-pharmacy and diagnostics are growing alongside it, fed by the same demand for easier access. Reaching patients outside the big cities is what keeps the numbers climbing.
Clean numbers are what convince backers this growth is real. A strong pitch deck opens doors, Ellty shows you exactly who opened your deck, and you can set granular permissions per fund.
Bigger rounds pull in global funds, and those funds expect regional scale rather than a single-country story. Pitching beyond Indonesia early signals that you can grow past your home market.
You will need proof that travels across borders, not just local traction. Showing results in more than one market makes a stronger case for a larger cheque.
Keep your data safe and ready so a global investor can review it without friction. Share one virtual data room link, watch who reads it inside Ellty, and see our ecommerce investors guide too.
Lead with clinical proof.
You have your Jakarta healthtech list ready. Set up a data room before the first call.


